Surgical Site Infections in Patients Receiving Osteomyocutaneous Free Flaps to the Head and Neck. Does Choice of Antibiotic Prophylaxis Matter?

Journal of Oral and Maxillofacial Surgery

Volumn 75, Issue 10, 2017, Pages 2223-2229

  Murphy, James ^a   Isaiah, Amal ^b   Dyalram, Donita ^a   Lubek, Joshua E ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; SULTAMICILLIN;

ADULT; AGED; ALCOHOL CONSUMPTION; AMELOBLASTOMA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE NECROSIS; CARDIOVASCULAR DISEASE; CIRCUMFLEX SCAPULAR ARTERY FLAP; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; DEEP CIRCUMFLEX ILIAC ARTERY FLAP; DIABETES MELLITUS; DRUG CHOICE; FEMALE; FIBULA GRAFT; HEAD AND NECK DISEASE; HEAD AND NECK SURGERY; HUMAN; IMMUNOPATHOLOGY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MYOCUTANEOUS FLAP; OSTEOMYOCUTANEOUS FREE FLAP; PERIPHERAL VASCULAR DISEASE; PEROPERATIVE CARE; PRIMARY TUMOR; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; SURGICAL INFECTION; TERTIARY CARE CENTER; TISSUE FLAP; TRACHEOSTOMY; TREATMENT DURATION; ADOLESCENT; BONE TRANSPLANTATION; FREE TISSUE GRAFT; HEAD AND NECK NEOPLASMS; MIDDLE AGED; SURGICAL WOUND INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; BONE TRANSPLANTATION; COHORT STUDIES; FEMALE; FREE TISSUE FLAPS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYOCUTANEOUS FLAP; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 85015953446     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2017.02.006     Document Type: Article

References (30)

1. Ogihara, H., Takeuchi, K., Majima, Y., Risk factors for post-operative infection in head and neck surgery. Auris Nasus Larynx, 36, 2009, 457.
2. Penel, N., Fournier, C., Lefebvre, D., et al. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery opening of mucosa. Study of 260 surgical procedures. Oral Oncol, 41, 2005, 35.
3. Simo, R., French, G., The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Surg, 14, 2006, 55.
4. Cohen, L.E., Finnerty, B., Golas, A.R., et al. Perioperative antibiotics in the setting of oropharyngeal reconstruction. Less is more. Ann Plast Surg, 76, 2014, 663.
5. Man, L.X., Beswick, D.M., Johnson, J.T., Antibiotic prophylaxis in uncontaminated neck dissection. Laryngoscope, 121, 2011, 1473.
6. Girod, D.A., McCulloch, T.M., Tsue, T.T., et al. Risk factors for complications in clean contaminated head and neck surgical procedures. Head Neck, 17, 1995, 7.
7. Lee, D.H., Kim, S.Y., Nam, S.Y., et al. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol, 47, 2011, 528.
8. Berard, F., Gandon, J., Postoperative wound infection: The influence of ultraviolet radiation of the operating room and various other factors. Ann Surg, 160, 1964, 1.
9. Kamizono, K., Sakuraba, M., Nagamatsu, S., et al. Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol, 21, 2014, 1700.
10. Rodrigo, J.P., Alvarez, J.C., Gomez, J.R., et al. Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck, 19, 1997, 188.
11. Becker, G.D., Parell, G.J., Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol, 88, 1979, 183.
12. Munday, G.S., Deveaux, P., Roberts, H., et al. Impact of implementation of the Surgical Care Improvement Project and future strategies for improving quality in surgery. Am J Surg, 208, 2014, 835.
13. Hawn, M.T., Vick, C.C., Richman, J., et al. Surgical site infection prevention: Time to move beyond the surgical care improvement program. Ann Surg, 254, 2011, 494.
14. Hirakawa, H., Hasegawa, Y., Hanai, N., et al. Surgical site infection in clean contaminated head and neck cancer surgery: risk factors and prognosis. Eur Arch Otorhinolaryngol, 270, 2013, 1115.
15. Cloke, D.J., Green, J.E., Khan, A.L., et al. Factors influencing the development of wound infection following free flap reconstruction for intra-oral cancer. Br J Plast Surg, 57, 2004, 556.
16. Callender, D.L., Antibiotic prophylaxis in head and neck oncologic surgery: The role of gram negative coverage. Int J Antimic Agents, 12, 1999, S21.
17. Russell, M.D., Goldberg, A.N., What is the evidence for use of antibiotic prophylaxis in clean contaminated head and neck surgery?. Laryngoscope, 122, 2012, 945.
18. Centers for Disease Control and Prevention. Surgical site infection (SSI). Event definitions. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf Published January 2015. Accessed March 06 2016.
19. Karakida, K., Aoki, T., Yamazaki, H., et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother, 16, 2010, 334.
20. Wong, C.H., Wei, F.C., Microsurgical free flap in head and neck reconstruction. Head Neck, 32, 2010, 1236.
21. Simons, J.P., Johnson, J.T., Yu, V.L., et al. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope, 111, 2001, 329.
22. Mitchell, R.M., Mendez, E., Schmitt, N.C., et al. Antibiotic prophylaxis in patients undergoing head and neck free flap reconstruction. JAMA Otolaryngol Head Neck Surg, 141, 2015, 1096.
23. Weber, R.S., Wound infection in head and neck surgery: Implications for perioperative antibiotic treatment. Ear Nose Throat J, 96, 1997, 790.
24. Durand, M.L., Yarlagadda, B.B., Rich, D.L., et al. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope, 125, 2015, 1084.
25. Pool, C., Kass, J., Spivack, J., et al. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg, 154, 2016, 272.
26. Grandis, J.R., Vickers, R.M., Rihs, J.D., et al. Efficacy of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate and clindamycin in contaminated head and neck surgery: Effect of antibiotic spectra and duration of therapy. J Infect Dis, 170, 1994, 729.
27. Yang, C.H., Chew, K.Y., Solomkin, J.S., et al. Surgical site infections among high risk patients in clean-contaminated head and neck reconstructive surgery: Concordance with preoperative oral flora. Ann Plast Surg, 71, 2013, S55.
28. Langerman, A., Thisted, R., Hohmann, S., et al. Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg, 154, 2016, 1054.
29. Carroll, W.R., Rosenstiel, D., Fix, J.R., et al. Three dose vs extended course clindamycin prophylaxis for free flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg, 129, 2003, 771.
30. Whiteside, T.L., Exosomes and tumor-mediated immune suppression. J Clin Invest, 126, 2016, 1216.